Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
The Lancet. Respiratory Medicine|December 25, 2016
A little CFTR can change a lot: slowing cystic fibrosis progressionSteven M Rowe
Handbook of Clinical Neurology|February 16, 2023
Lessons from other fields of medicine, Part 2: Cystic fibrosisKadambari Vijaykumar, Steven M Rowe
BMC Gastroenterology|July 13, 2019
The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case reportJ Dixon Johns, Steven M Rowe
BMJ (Clinical Research Ed.)|April 1, 2016
New and emerging targeted therapies for cystic fibrosisBradley S Quon, Steven M Rowe
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 20, 2018
Not simply the lesser of two evilsS Vamsee Raju, Steven M Rowe
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 25, 2009
Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in developmentSteven M Rowe, John P Clancy
Current Opinion in Pediatrics|November 14, 2006
Advances in cystic fibrosis therapiesSteven M Rowe, John P Clancy
Current Opinion in Pulmonary Medicine|September 11, 2010
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosisPeter A Sloane, Steven M Rowe
The Journal of Clinical Investigation|September 17, 2019
Revealing the molecular signaling pathways of mucus stasis in cystic fibrosisSusan E Birket, Steven M Rowe
Cold Spring Harbor Perspectives in Medicine|July 3, 2013
Cystic fibrosis transmembrane regulator correctors and potentiatorsSteven M Rowe, Alan S Verkman
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
The Lancet. Respiratory Medicine|December 25, 2016
A little CFTR can change a lot: slowing cystic fibrosis progressionSteven M Rowe
Handbook of Clinical Neurology|February 16, 2023
Lessons from other fields of medicine, Part 2: Cystic fibrosisKadambari Vijaykumar, Steven M Rowe
BMC Gastroenterology|July 13, 2019
The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case reportJ Dixon Johns, Steven M Rowe
BMJ (Clinical Research Ed.)|April 1, 2016
New and emerging targeted therapies for cystic fibrosisBradley S Quon, Steven M Rowe
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 20, 2018
Not simply the lesser of two evilsS Vamsee Raju, Steven M Rowe
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 25, 2009
Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in developmentSteven M Rowe, John P Clancy
Current Opinion in Pediatrics|November 14, 2006
Advances in cystic fibrosis therapiesSteven M Rowe, John P Clancy
Current Opinion in Pulmonary Medicine|September 11, 2010
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosisPeter A Sloane, Steven M Rowe
The Journal of Clinical Investigation|September 17, 2019
Revealing the molecular signaling pathways of mucus stasis in cystic fibrosisSusan E Birket, Steven M Rowe
Cold Spring Harbor Perspectives in Medicine|July 3, 2013
Cystic fibrosis transmembrane regulator correctors and potentiatorsSteven M Rowe, Alan S Verkman
Pageof 27